German pharmacists demand fairer pay after €3.5B health insurance surplus
Germany's statutory health insurance system recorded a €3.5 billion surplus in 2022, sparking frustration among pharmacists. Frank-Martin Welzig, owner of Hils Pharmacy in Delligsen, Lower Saxony, has written to Health Minister Nina Warken to protest the handling of these funds. He argues that pharmacies, who helped generate the surplus, are not receiving fair compensation in return.
The surplus stems partly from discount contracts negotiated by pharmacies. Yet, despite their role in creating savings, Welzig claims the profession is being overlooked. In January 2024, the fixed dispensing fee per prescription rose from €0.70 to €1.00, with further adjustments expected. This change came under the Pharmacy Strengthening Act, which also introduced higher reimbursement rates, better compensation for deliveries, and support for independent pharmacies struggling with rising costs and online competition.
Welzig has criticised the latest draft pharmacy reform for failing to increase the fixed fee further. He described it as a 'slap in the face' to the entire sector. Meanwhile, the National Association of Statutory Health Insurance Funds (GKV-Spitzenverband) insists the surplus remains insufficient to rebuild reserves.
Pharmacists also face the added burden of explaining medication switches to patients. These changes often lead to confusion, extra workload, and potential issues with treatment adherence.
The dispute highlights tensions between pharmacies and health insurers over funding distribution. While the 2024 reforms provided some financial relief, Welzig's protest suggests deeper dissatisfaction within the profession. The outcome of his appeal to the health minister could influence future policy decisions.
